Asymmetry Capital Management, L.P.

Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2021		-6.1%	$0	0	-229,117	-100%	$14.85	Q4 2021
30 Sep 2021	6.1%	+6.1%	$10,152,000	229,117	+229,117	NEW	$44.31	Q3 2021
30 Jun 2021		-3.1%	$0	0	-79,650	-100%	$14.85	Q2 2021
31 Mar 2021	3.1%	-3.9%	$5,962,000	79,650	-102,000	-56%	$74.85	Q1 2021
31 Dec 2020	7.3%	+3.2%	$15,715,000	181,650	+79,188	+77%	$86.51	Q4 2020
30 Sep 2020	4%	-3.7%	$6,262,000	102,462	-94,787	-48%	$61.12	Q3 2020
30 Jun 2020	6.3%	+6.3%	$8,202,000	197,249	+197,249	NEW	$41.58	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.